Long-term diazepam treatment enhances microglial spine engulfment and impairs cognitive performance via the mitochondrial 18 kDa translocator protein (TSPO).


Journal

Nature neuroscience
ISSN: 1546-1726
Titre abrégé: Nat Neurosci
Pays: United States
ID NLM: 9809671

Informations de publication

Date de publication:
03 2022
Historique:
received: 29 10 2019
accepted: 14 01 2022
pubmed: 2 3 2022
medline: 27 4 2022
entrez: 1 3 2022
Statut: ppublish

Résumé

Benzodiazepines are widely administered drugs to treat anxiety and insomnia. In addition to tolerance development and abuse liability, their chronic use may cause cognitive impairment and increase the risk for dementia. However, the mechanism by which benzodiazepines might contribute to persistent cognitive decline remains unknown. Here we report that diazepam, a widely prescribed benzodiazepine, impairs the structural plasticity of dendritic spines, causing cognitive impairment in mice. Diazepam induces these deficits via the mitochondrial 18 kDa translocator protein (TSPO), rather than classical γ-aminobutyric acid type A receptors, which alters microglial morphology, and phagocytosis of synaptic material. Collectively, our findings demonstrate a mechanism by which TSPO ligands alter synaptic plasticity and, as a consequence, cause cognitive impairment.

Identifiants

pubmed: 35228700
doi: 10.1038/s41593-022-01013-9
pii: 10.1038/s41593-022-01013-9
doi:

Substances chimiques

Bzrp protein, mouse 0
Mitochondrial Proteins 0
Receptors, GABA 0
Benzodiazepines 12794-10-4
Diazepam Q3JTX2Q7TU

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

317-329

Informations de copyright

© 2022. The Author(s), under exclusive licence to Springer Nature America, Inc.

Références

Rudolph, U. & Knoflach, F. Beyond classical benzodiazepines: novel therapeutic potential of GABA
pmcid: 3375401 doi: 10.1038/nrd3502
Rupprecht, R. et al. Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders. Nat. Rev. Drug Discov. 9, 971–988 (2010).
doi: 10.1038/nrd3295
Papadopoulos, V. et al. Translocator protein (18 kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. Trends Pharmacol. Sci. 27, 402–409 (2006).
pubmed: 16822554 doi: 10.1016/j.tips.2006.06.005
Liu, G.-J. et al. Functional gains in energy and cell metabolism after TSPO gene insertion. Cell Cycle 16, 436–447 (2017).
pubmed: 28103132 pmcid: 5351937 doi: 10.1080/15384101.2017.1281477
Gut, P., Zweckstetter, M. & Banati, R. B. Lost in translocation: the functions of the 18-kD translocator protein. Trends Endocrinol. Metab. 26, 349–356 (2015).
pubmed: 26026242 pmcid: 5654500 doi: 10.1016/j.tem.2015.04.001
Barker, M. J., Greenwood, K. M., Jackson, M. & Crowe, S. F. Cognitive effects of long-term benzodiazepine use. CNS Drugs 18, 37–48 (2004).
pubmed: 14731058 doi: 10.2165/00023210-200418010-00004
Arolfo, M. P. & Brioni, J. D. Diazepam impairs place learning in the Morris water maze. Behav. Neural Biol. 55, 131–136 (1991).
pubmed: 1996944 doi: 10.1016/0163-1047(91)80133-Y
Gallacher, J. et al. Benzodiazepine use and risk of dementia: evidence from the Caerphilly Prospective Study (CaPS). J. Epidemiol. Community Health 66, 869–873 (2012).
pubmed: 22034632 doi: 10.1136/jech-2011-200314
de Gage, S. B. et al. Benzodiazepine use and risk of Alzheimer’s disease: case–control study. BMJ 349, g5205 (2014).
doi: 10.1136/bmj.g5205
Penninkilampi, R. & Eslick, G. D. A systematic review and meta-analysis of the risk of dementia associated with benzodiazepine use, after controlling for protopathic bias. CNS Drugs 32, 485–497 (2018).
pubmed: 29926372 doi: 10.1007/s40263-018-0535-3
Gray, S. L. et al. Benzodiazepine use and risk of incident dementia or cognitive decline: prospective population based study. BMJ 352, i90 (2016).
pubmed: 26837813 pmcid: 4737849 doi: 10.1136/bmj.i90
Biétry, F. A., Pfeil, A. M., Reich, O., Schwenkglenks, M. & Meier, C. R. Benzodiazepine use and risk of developing Alzheimer’s disease: a case–control study based on Swiss claims data. CNS Drugs 31, 245–251 (2017).
pubmed: 28078633 doi: 10.1007/s40263-016-0404-x
Kasai, H., Fukuda, M., Watanabe, S., Hayashi-Takagi, A. & Noguchi, J. Structural dynamics of dendritic spines in memory and cognition. Trends Neurosci. 33, 121–129 (2010).
pubmed: 20138375 doi: 10.1016/j.tins.2010.01.001
Zou, C. et al. Neuroinflammation impairs adaptive structural plasticity of dendritic spines in a preclinical model of Alzheimer’s disease. Acta Neuropathol. 131, 235–246 (2016).
pubmed: 26724934 pmcid: 4713725 doi: 10.1007/s00401-015-1527-8
Zuo, Y., Lin, A., Chang, P. & Gan, W.-B. Development of long-term dendritic spine stability in diverse regions of cerebral cortex. Neuron 46, 181–189 (2005).
pubmed: 15848798 doi: 10.1016/j.neuron.2005.04.001
Grutzendler, J., Kasthuri, N. & Gan, W.-B. Long-term dendritic spine stability in the adult cortex. Nature 420, 812–816 (2002).
pubmed: 12490949 doi: 10.1038/nature01276
Feng, G. et al. Imaging neuronal subsets in transgenic mice expressing multiple spectral variants of GFP. Neuron 28, 41–51 (2000).
pubmed: 11086982 doi: 10.1016/S0896-6273(00)00084-2
Rudolph, U. et al. Benzodiazepine actions mediated by specific γ-aminobutyric acid
pubmed: 10548105 doi: 10.1038/44579
Richter, L. et al. Diazepam-bound GABA
pmcid: 3368153 doi: 10.1038/nchembio.917
Ralvenius, W. T., Benke, D., Acuna, M. A., Rudolph, U. & Zeilhofer, H. U. Analgesia and unwanted benzodiazepine effects in point-mutated mice expressing only one benzodiazepine-sensitive GABA
pubmed: 25865415 pmcid: 4829939 doi: 10.1038/ncomms7803
Sohal, V. S., Zhang, F., Yizhar, O. & Deisseroth, K. Parvalbumin neurons and gamma rhythms enhance cortical circuit performance. Nature 459, 698–702 (2009).
pubmed: 19396159 pmcid: 3969859 doi: 10.1038/nature07991
Hu, H., Gan, J. & Jonas, P. Fast-spiking, parvalbumin
pubmed: 25082707 doi: 10.1126/science.1255263
Pritchett, D. B. & Seeburg, P. H. γ‐Aminobutyric acid
pubmed: 2157817 doi: 10.1111/j.1471-4159.1990.tb01237.x
Romeo, E. et al. 2-Aryl-3-indoleacetamides (FGIN-1): a new class of potent and specific ligands for the mitochondrial DBI receptor (MDR). J. Pharmacol. Exp. Ther. 262, 971–978 (1992).
pubmed: 1326631
Löw, K. et al. Molecular and neuronal substrate for the selective attenuation of anxiety. Science 290, 131–134 (2000).
pubmed: 11021797 doi: 10.1126/science.290.5489.131
Crestani, F. et al. Trace fear conditioning involves hippocampal α
pubmed: 12084936 pmcid: 124409 doi: 10.1073/pnas.142288699
Banati, R. B. et al. Positron emission tomography and functional characterization of a complete PBR/TSPO knockout. Nat. Commun. 5, 5452 (2014).
pubmed: 25406832 doi: 10.1038/ncomms6452
Brendel, M. et al. Glial activation and glucose metabolism in a transgenic amyloid mouse model: a triple-tracer PET study. J. Nucl. Med. 57, 954–960 (2016).
pubmed: 26912428 doi: 10.2967/jnumed.115.167858
Kreisl, W. C. et al. In vivo radioligand binding to translocator protein correlates with severity of Alzheimer’s disease. Brain 136, 2228–2238 (2013).
pubmed: 23775979 pmcid: 3692038 doi: 10.1093/brain/awt145
Cagnin, A. et al. In-vivo measurement of activated microglia in dementia. Lancet 358, 461–467 (2001).
pubmed: 11513911 doi: 10.1016/S0140-6736(01)05625-2
Wolf, L. et al. Enhancing neurosteroid synthesis—relationship to the pharmacology of translocator protein (18 kDa)(TSPO) ligands and benzodiazepines. Pharmacopsychiatry 48, 72–77 (2015).
pubmed: 25654303 doi: 10.1055/s-0035-1558003
Salter, M. W. & Stevens, B. Microglia emerge as central players in brain disease. Nat. Med. 23, 1018–1027 (2017).
pubmed: 28886007 doi: 10.1038/nm.4397
Wake, H., Moorhouse, A. J., Miyamoto, A. & Nabekura, J. Microglia: actively surveying and shaping neuronal circuit structure and function. Trends Neurosci. 36, 209–217 (2013).
pubmed: 23260014 doi: 10.1016/j.tins.2012.11.007
Hong, S. et al. Complement and microglia mediate early synapse loss in Alzheimer mouse models. Science 352, 712–716 (2016).
pubmed: 27033548 pmcid: 5094372 doi: 10.1126/science.aad8373
Chung, W.-S., Welsh, C. A., Barres, B. A. & Stevens, B. Do glia drive synaptic and cognitive impairment in disease? Nat. Neurosci. 18, 1539–1545 (2015).
pubmed: 26505565 pmcid: 4739631 doi: 10.1038/nn.4142
Elmore, M. R. et al. Colony-stimulating factor 1 receptor signaling is necessary for microglia viability, unmasking a microglia progenitor cell in the adult brain. Neuron 82, 380–397 (2014).
pubmed: 24742461 pmcid: 4161285 doi: 10.1016/j.neuron.2014.02.040
Paolicelli, R. C. et al. Synaptic pruning by microglia is necessary for normal brain development. Science 333, 1456–1458 (2011).
pubmed: 21778362 doi: 10.1126/science.1202529
Neniskyte, U. & Gross, C. T. Errant gardeners: glial-cell-dependent synaptic pruning and neurodevelopmental disorders. Nat. Rev. Neurosci. 18, 658–670 (2017).
pubmed: 28931944 doi: 10.1038/nrn.2017.110
Dejanovic, B. et al. Changes in the synaptic proteome in tauopathy and rescue of tau-induced synapse loss by C1q antibodies. Neuron 100, 1322–1336 (2018).
pubmed: 30392797 doi: 10.1016/j.neuron.2018.10.014
Liu, Y. U. et al. Neuronal network activity controls microglial process surveillance in awake mice via norepinephrine signaling. Nat. Neurosci. 22, 1771–1781 (2019).
pubmed: 31636449 pmcid: 6858573 doi: 10.1038/s41593-019-0511-3
Umpierre, A. D. & Wu, L. J. How microglia sense and regulate neuronal activity. Glia 69, 1637–1653 (2021).
pubmed: 33369790 doi: 10.1002/glia.23961
Zhang, Y., Zhou, X.-h, Meranus, D. H., Wang, L. & Kukull, W. A. Benzodiazepine use and cognitive decline in elderly with normal cognition. Alzheimer Dis. Assoc. Disord. 30, 113–117 (2016).
pmcid: 4670597 doi: 10.1097/WAD.0000000000000099
Pariente, A., de Gage, S. B., Moore, N. & Bégaud, B. The benzodiazepine–dementia disorders link: current state of knowledge. CNS Drugs 30, 1–7 (2016).
pubmed: 26715389 doi: 10.1007/s40263-015-0305-4
Filipello, F. et al. The microglial innate immune receptor TREM2 is required for synapse elimination and normal brain connectivity. Immunity 48, 979–991 (2018).
pubmed: 29752066 doi: 10.1016/j.immuni.2018.04.016
Paolicelli, R. C. et al. TDP-43 depletion in microglia promotes amyloid clearance but also induces synapse loss. Neuron 95, 297–308 (2017).
pubmed: 28669544 pmcid: 5519492 doi: 10.1016/j.neuron.2017.05.037
Lechin, F. et al. Peripheral blood immunological parameters in long-term benzodiazepine users. Clin. Neuropharmacol. 17, 63–72 (1994).
Covelli, V. et al. Effects of benzodiazepines on the immune system. Acta Neurologica 13, 418–423 (1991).
pubmed: 1776530
Colasanti, A. et al. Bipolar disorder is associated with the rs6971 polymorphism in the gene encoding 18 kDa translocator protein (TSPO). Psychoneuroendocrinology 38, 2826–2829 (2013).
pubmed: 23942012 pmcid: 3820042 doi: 10.1016/j.psyneuen.2013.07.007
Jung, S. et al. Analysis of fractalkine receptor CX
pubmed: 10805752 pmcid: 85780 doi: 10.1128/MCB.20.11.4106-4114.2000
Fuhrmann, M., Mitteregger, G., Kretzschmar, H. & Herms, J. Dendritic pathology in prion disease starts at the synaptic spine. J. Neurosci. 27, 6224–6233 (2007).
pubmed: 17553995 pmcid: 6672160 doi: 10.1523/JNEUROSCI.5062-06.2007
Mrsic-Flogel, T. D. et al. Homeostatic regulation of eye-specific responses in visual cortex during ocular dominance plasticity. Neuron 54, 961–972 (2007).
pubmed: 17582335 doi: 10.1016/j.neuron.2007.05.028
Deussing, M. et al. Coupling between physiological TSPO expression in brain and myocardium allows stabilization of late-phase cerebral [
pubmed: 28988133 doi: 10.1016/j.neuroimage.2017.10.006
Kleinberger, G. et al. The FTD‐like syndrome causing TREM2 T66M mutation impairs microglia function, brain perfusion, and glucose metabolism. EMBO J. 36, 1837–1853 (2017).
pubmed: 28559417 pmcid: 5494459 doi: 10.15252/embj.201796516
Leger, M. et al. Object recognition test in mice. Nat. Protoc. 8, 2531–2537 (2013).
doi: 10.1038/nprot.2013.155

Auteurs

Yuan Shi (Y)

Center for Neuropathology, Ludwig Maximilian University of Munich, Munich, Germany.
German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.
Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.
Munich Medical Research School, Ludwig Maximilian University of Munich, Munich, Germany.

Mochen Cui (M)

Center for Neuropathology, Ludwig Maximilian University of Munich, Munich, Germany.
German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.
Munich Medical Research School, Ludwig Maximilian University of Munich, Munich, Germany.

Katharina Ochs (K)

Center for Neuropathology, Ludwig Maximilian University of Munich, Munich, Germany.
German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.

Matthias Brendel (M)

Department of Nuclear Medicine, University Hospital of Munich, Ludwig Maximilian University of Munich, Munich, Germany.

Felix L Strübing (FL)

Center for Neuropathology, Ludwig Maximilian University of Munich, Munich, Germany.
German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.

Nils Briel (N)

Center for Neuropathology, Ludwig Maximilian University of Munich, Munich, Germany.
German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.
Munich Medical Research School, Ludwig Maximilian University of Munich, Munich, Germany.

Florian Eckenweber (F)

Department of Nuclear Medicine, University Hospital of Munich, Ludwig Maximilian University of Munich, Munich, Germany.

Chengyu Zou (C)

Center for Neuropathology, Ludwig Maximilian University of Munich, Munich, Germany.
German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.
Interdisciplinary Research Center on Biology and Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai, China.

Richard B Banati (RB)

Australian Nuclear Science and Technology Organisation (ANSTO), Sydney NSW, Australia.
Brain and Mind Centre, Medical Imaging Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney NSW, Australia.

Guo-Jun Liu (GJ)

Australian Nuclear Science and Technology Organisation (ANSTO), Sydney NSW, Australia.
Brain and Mind Centre, Medical Imaging Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney NSW, Australia.

Ryan J Middleton (RJ)

Australian Nuclear Science and Technology Organisation (ANSTO), Sydney NSW, Australia.

Rainer Rupprecht (R)

Department of Psychiatry and Psychotherapy, University of Regensburg, Regensburg, Germany.

Uwe Rudolph (U)

Department of Comparative Biosciences, College of Veterinary Medicine, and Carl R. Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, IL, USA.

Hanns Ulrich Zeilhofer (HU)

Institute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland.
Institute of Pharmaceutical Sciences, Swiss Federal Institute of Technology (ETH) Zurich, Zurich, Switzerland.

Gerhard Rammes (G)

Department of Anesthesiology and Intensive Care Medicine, Klinikum rechts der Isar, Technische Universität München, Munich, Germany.

Jochen Herms (J)

Center for Neuropathology, Ludwig Maximilian University of Munich, Munich, Germany. jochen.herms@dzne.de.
German Center for Neurodegenerative Diseases (DZNE), Munich, Germany. jochen.herms@dzne.de.
Munich Cluster for Systems Neurology (SyNergy), Munich, Germany. jochen.herms@dzne.de.

Mario M Dorostkar (MM)

Center for Neuropathology, Ludwig Maximilian University of Munich, Munich, Germany. mario.dorostkar@med.uni-muenchen.de.
German Center for Neurodegenerative Diseases (DZNE), Munich, Germany. mario.dorostkar@med.uni-muenchen.de.

Articles similaires

Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice
Animals Tail Swine Behavior, Animal Animal Husbandry

Classifications MeSH